Natasha Galasso

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas”.

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Blood(2021)10.1182/blood.2021013379

N/A

4.9DataRank · unranked

180 citations

Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor +31 more

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024014263

N/A

0.113DataRank · unranked

1 citations

Parastoo B. Dahi, Farhad Khimani, Andrei R. Shustov, Mazyar Shadman, Jia Ruan +19 more

Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants

Journal of Plastic Reconstructive & Aesthetic Surgery(2020)10.1016/j.bjps.2019.11.064

N/A

0DataRank · unranked

185 citations

Paola Ghione, Ai Ni, Qunying Hu, Nivetha Ganesan, Natasha Galasso +3 more

Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis

Haematologica(2024)10.3324/haematol.2023.284179

N/A

0DataRank · unranked

8 citations

Zachary D. Epstein‐Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Phuong Dao +21 more

BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants

Blood Advances(2025)10.1182/bloodadvances.2025016810

N/A

0DataRank · unranked

2 citations

Diana Mandelker, Maria E. Arcila, Venkatraman Seshan, Mary Beth Terry, Vijai Joseph +11 more

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Blood Advances(2023)10.1182/bloodadvances.2023009953

N/A

0DataRank · unranked

28 citations

Nivetha Ganesan, Zachary D. Epstein‐Peterson, Alison J. Moskowitz, Robert Stuver, Catherine Maccaro +27 more

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2020002396

N/A

0DataRank · unranked

96 citations

Promie Faruque, Neha Mehta–Shah, Venkatraman Seshan, Neval Özkaya, Shakthi Bhaskar +15 more